<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>A deep learning model to reduce agent dose for contrast-enhanced MRI of the cerebellopontine angle cistern - Health AI Hub</title>
    <meta name="description" content="This study developed and evaluated a deep learning (DL) model to significantly reduce the contrast agent dose required for T1-weighted contrast-enhanced MRI (T1">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>A deep learning model to reduce agent dose for contrast-enhanced MRI of the cerebellopontine angle cistern</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.20926v1" target="_blank">2511.20926v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-25
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yunjie Chen, Rianne A. Weber, Olaf M. Neve, Stephan R. Romeijn, Erik F. Hensen, Jelmer M. Wolterink, Qian Tao, Marius Staring, Berit M. Verbist
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.20926v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.20926v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This study developed and evaluated a deep learning (DL) model to significantly reduce the contrast agent dose required for T1-weighted contrast-enhanced MRI (T1ce) of the cerebellopontine angle (CPA) cistern. The DL model successfully restored high-quality images from simulated low-dose acquisitions, enabling lesion detection and diagnostic characterization with only 10% to 30% of the standard contrast agent dose, as validated by both quantitative metrics and radiologist evaluation.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Reducing contrast agent dose in MRI is crucial for patient safety, mitigating risks like nephrogenic systemic fibrosis and gadolinium retention, especially for patients with renal impairment. This deep learning approach offers a pathway to maintain diagnostic image quality while significantly lowering patient exposure to contrast agents and potentially reducing costs.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application involves using a deep learning model to reconstruct high-quality, standard-dose equivalent MRI images from low-dose contrast-enhanced scans. This enhances diagnostic capabilities in medical imaging while simultaneously reducing the patient's exposure to contrast agents, thereby improving patient safety and healthcare efficiency.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>A deep learning (DL) model was developed to restore standard-dose T1ce MRI quality from simulated low-dose images of the cerebellopontine angle (CPA) cistern.</li>
                    
                    <li>The study utilized a multi-center retrospective dataset of T1 and T1ce MRI scans from 72 vestibular schwannoma (VS) patients to simulate varying levels of contrast agent dose reduction.</li>
                    
                    <li>DL-restored images showed significant improvements in quantitative image quality metrics, with SSIM increasing from 0.639 to 0.993 and PSNR from 21.6 dB to 41.4 dB as input dose increased.</li>
                    
                    <li>At a simulated 10% input dose, the DL model substantially improved segmentation performance for lesions, increasing the Dice score from 0.673 to 0.734 and reducing the 95% Hausdorff distance from 2.38 mm to 2.07 mm.</li>
                    
                    <li>Radiological review by a head and neck radiologist indicated that DL-restored T1ce images from both 10% and 30% input doses were of excellent quality, with the 30% dose restoration being considered more diagnostically informative.</li>
                    
                    <li>The findings suggest that contrast-enhanced MRI of the CPA cistern can be performed effectively using 10-30% of the standard contrast agent dose when combined with DL image restoration.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>This was a multi-center retrospective study involving T1 and T1ce MRI data from 72 vestibular schwannoma patients. Low-dose T1ce images were simulated from existing standard-dose T1ce data. Deep learning models were then trained to restore these simulated low-dose images to standard-dose quality. The performance was evaluated quantitatively using structural similarity index measure (SSIM), peak signal-to-noise ratio (PSNR), and segmentation metrics (Dice, 95% Hausdorff distance, average surface distance), as well as qualitatively through diagnostic characterization by a head and neck radiologist.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The DL model significantly improved image quality metrics, with SSIM reaching 0.993 ¬± 0.009 and PSNR 41.4 ¬± 4.84 dB at higher input doses. For 10% input dose, segmentation Dice score improved from 0.673 to 0.734, 95% Hausdorff distance reduced from 2.38 mm to 2.07 mm, and average surface distance decreased from 1.00 mm to 0.59 mm. Radiologist assessment confirmed excellent diagnostic quality for 10% and 30% dose-restored images, with the latter being more informative.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research provides a robust method to enable substantial reduction (70-90%) in contrast agent dose for CPA cistern MRI, potentially leading to enhanced patient safety by minimizing risks associated with gadolinium-based contrast agents, reducing healthcare costs, and expanding access to contrast-enhanced MRI for a wider range of patients, including those with compromised renal function.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract, but inherent limitations of this study might include its retrospective nature, the simulation-based approach for low-dose images rather than prospective acquisition, and potential generalizability issues to other anatomical regions or pathologies.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly mentioned in the abstract, but potential future directions could involve prospective clinical trials to validate the DL model's performance in real-world low-dose acquisitions, evaluating its efficacy across different MRI scanners and patient populations, and extending the approach to other contrast-enhanced MRI applications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Neuroradiology</span>
                    
                    <span class="tag">Otolaryngology</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Deep learning</span>
                    
                    <span class="tag tag-keyword">MRI</span>
                    
                    <span class="tag tag-keyword">Contrast agent reduction</span>
                    
                    <span class="tag tag-keyword">Cerebellopontine angle</span>
                    
                    <span class="tag tag-keyword">Vestibular schwannoma</span>
                    
                    <span class="tag tag-keyword">Image quality</span>
                    
                    <span class="tag tag-keyword">Segmentation</span>
                    
                    <span class="tag tag-keyword">Dose optimization</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Objectives: To evaluate a deep learning (DL) model for reducing the agent dose of contrast-enhanced T1-weighted MRI (T1ce) of the cerebellopontine angle (CPA) cistern. Materials and methods: In this multi-center retrospective study, T1 and T1ce of vestibular schwannoma (VS) patients were used to simulate low-dose T1ce with varying reductions of contrast agent dose. DL models were trained to restore standard-dose T1ce from the low-dose simulation. The image quality and segmentation performance of the DL-restored T1ce were evaluated. A head and neck radiologist was asked to rate DL-restored images in multiple aspects, including image quality and diagnostic characterization. Results: 203 MRI studies from 72 VS patients (mean age, 58.51 \pm 14.73, 39 men) were evaluated. As the input dose increased, the structural similarity index measure of the restored T1ce increased from 0.639 \pm 0.113 to 0.993 \pm 0.009, and the peak signal-to-noise ratio increased from 21.6 \pm 3.73 dB to 41.4 \pm 4.84 dB. At 10% input dose, using DL-restored T1ce for segmentation improved the Dice from 0.673 to 0.734, the 95% Hausdorff distance from 2.38 mm to 2.07 mm, and the average surface distance from 1.00 mm to 0.59 mm. Both DL-restored T1ce from 10% and 30% input doses showed excellent images, with the latter being considered more informative. Conclusion: The DL model improved the image quality of low-dose MRI of the CPA cistern, which makes lesion detection and diagnostic characterization possible with 10% - 30% of the standard dose.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>